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Conventional Prokaryotic Expression Systems
In prokaryotes there is only one RNA polymerase (RNAP), which 
is responsible for transcribing all genes. RNAP is a holoenzyme 
constituted by a minimum of four subunits (α
2
ββ'). Specificity 
for a defined promoter group is given by an additional protein 
named sigma (σ), which binds α
2
ββ' prior to its assembly to the 
promoter. There is a plethora of sigma and anti-sigma factors, 
which in turn represents a first mayor level of regulation.1,2 The 
minimal functional promoter recognized by σ70 is constituted by 
two hexamers spaced by 17 bp, namely the -35 and -10 boxes. 
Depending on the similarity between the real promoter and the 
consensus, the efficiency of the transcription initiation may dif-
fer. As a general rule, strong promoters tend to be repressed whilst 
weak promoters require activators to proceed with transcription 
initiation.3 Following the assemblage of the RNAP over the pro-
moter, the complex passes through different stages prior to tran-
scription initiation. First, the initial recognition occurs between 
the RNAP-sigma and the promoter face, covering from -50 to 
+20 from the transcription start site. In terms of the status of the 
double helix, this conformation is known as closed complex and 
follows a reversible dynamic equilibrium until the promoter is 
opened between -10 up to +8. This new configuration is known as 
open complex. Then, RNAP starts a series of short abortive series 
of elongation (2–8 bases RNA transcripts) in a state called ini-
tiation complex. Finally, one of these transcriptions escape from 
the promoter, the sigma factor is released and the RNAP turn 
fully processive as an elongation complex.4 Each of these steps 
carries a series of conformational changes in the RNAP that can 
be favored (by activators) or retained (by repressors). Nowadays, 
we can find several examples in the market of expression systems 
excised from their natural environments and redesign in order to 
fulfill the requirements of biotechnologists.
Expression vectors appear to be an indispensable tool for 
both biological studies and biotechnological applications. 
Controlling gene overexpression becomes a critical issue 
when protein production is desired. In addition to several 
aspects regarding toxicity or plasmid instability, tight control 
of gene expression is an essential factor in biotechnological 
processes. Thus, the search for better-controlled circuits is 
an important issue among biotechnologists. Traditionally, 
expression systems involve a single regulatory protein 
operating over a target promoter. However, these circuits 
are limited on their induction ratios (e.g., by their restriction 
in the maximal expression capacity, by their leakiness under 
non-induced conditions). Due to these limitations, regulatory 
cascades, which are far more efficient, are necessary for 
biotechnological applications. Thus, regulatory circuits 
with two modules operating in cascade offer a significant 
advantage. In this review, we describe the regulatory cascade 
based on two salicylate-responsive transcriptional regulators 
of Pseudomonas putida (nahR/Psal::xylS2), its properties, and 
contribution to a tighter control over heterologous gene 
expression in different applications.
Nowadays, heterologous expression has been proven to be 
an indispensable tool for tackling basic biological questions, 
as well as for developing biotechnological applications. As 
the nature of the protein of interest becomes more complex, 
biotechnologists find that a tight control of gene expression is 
a key factor which conditions the success of the downstream 
purification process, as well as the interpretation of the re-
sults in other type of studies. Fortunately, different expression 
systems can be found in the market, each of them with their 
own pros and cons. In this review we discuss the exploita-
tion of prokaryotic expression systems based on a promising 
expression system, the salicylate-dependent control circuit 
encompassing nahR/Psal::xylS2, as well as some of the improve-
ments that have been done on this system to exploit it more 
efficiently in the context of both biotechnological applications 
and basic research.
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REVIEW
Expression System Based on PBAD
This expression system has an interesting feature that makes it 
attractive, the regulatory protein AraC acts over the P
BAD
, not 
only as repressor in the absence of arabinose (Fig. 1A), but also 
as inducer in the presence of the inductor (Fig. 1B). The sys-
tem encompasses two divergent promoters, P
c
, that controls the 
expression of araC and, P
BAD
, driving the expression of the gene 
of interest. In the absence of arabinose, AraC forms a loop hid-
ing the P
BAD
 promoter. When arabinose is present, AraC free the 
loops and actively promote the transcription from P
BAD
.7
Expression System Based on PT7
This system consists on a modular system with two elements. The 
first module comprises the P
lacUV5
 normally inserted in the strain 
chromosome, driving the expression of the gene-1 from phage 
T7, encoding its own RNA polymerase. The second element is 
placed in a multicopy plasmid and contains the P
T7
, driving the 
expression of the gene of interest. This system takes advantage of 
the tremendous processivity of the T7 RNAP, and controlling 
its presence by using IPTG. The main problem of this system is 
basically the high basal transcription. Leakiness from the P
lacuv5
 is 
Expression Systems Based on Plac Derivates
Under natural conditions, lactose enters the cell through a perme-
ase and binds the LacI repressor, changing its conformation and 
preventing its action over the lacO site, thereby leaving the RNA 
polymerase free to access the P
lac
 promoter (Fig. 1A). On its bio-
technological application, induction takes place through a non-
metabolized inducer: isopropyl-β-D-thiogalactoside (IPTG). 
This also allows the use of the P
lac
 expression system in organisms 
lacking the lactose permease. However, this promoter is rather 
weak, limiting the maximum expression rate. Hybrid promoters 
P
tac
 and P
trc
, exert the strong expression capacity derived from the 
P
trp
 together with the repression capacity mediated by LacI. P
tac
 
consists of the -35 box from the trp promoter and the -10 box 
from the lac promoter with a spacer just one bp larger than the 
wild type promoter. By using this modified system it is possible 
to accumulate up to 15–30% of the protein of interest of the 
total dry cell weight.5 On the other hand, lacI has been also sub-
jected to improvement. Certain point mutation placed on the -35 
box of the own P
lacI
 generate a higher number of LacI in the cell 
(from 20 to 100 molecules per cell). This allele named lacIq favors 
the binding to the lacO region allowing a tighten repression and 
diminishing the basal levels of expression.6
Figure 1. Induction can be under positive or negative control. (A) Negative control: induction is achieved when an inducer inactivates a repressor 
protein allowing the expression of the gene of interest. (B) Positive control: induction is achieved when an inducer activates an activator protein.
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On the other hand, the nahR/P
sal
 expression system has its 
origin in the catabolic genes of plasmid NAH7 of P. putida for 
degradation of naphthalene, which is controlled by a single regu-
latory protein (NahR) that is activated by salicylate, one of the 
intermediates of the catabolic pathway.22 Despite the structural 
similarity between salicylate and benzoate, the transcriptional 
activator NahR of the NAH pathway belongs to the LysR family, 
which is unrelated to XylS/AraC family.23 Members from this 
family respond to several chemical inducers under natural con-
ditions, being transcribed divergently from its target promoter, 
in a process which is accomplished by an autoregulatory circuit. 
LysR-type regulators stay bound to their target sequences even in 
the absence of inductor, thereby allowing a rapid activation.24,25 
Although these two systems are unrelated, it is important to 
remark that XylS mutants that respond to salicylate can be iso-
lated, such as XylS2,26 as well as NahR mutants responding to 
benzoate.27
Rationale of the Transcriptional Cascade Based  
on nahR and xylS2
The simplest regulatory cascades are found in prokaryotic sys-
tems and they typically involve at least two different transcrip-
tional activators. These are arranged in such a fashion that a 
first regulatory component (upstream regulator) controls the 
expression of a second regulatory gene (downstream regulator) 
in response to specific signals. In turn, the downstream compo-
nent acts directly on transcription of the structural genes of the 
system. Cebolla et al.28 designed a cascade using two salicylate-
responsive transcriptional regulators of P. putida and analyzed 
experimentally the conditions under which two activators could 
be coupled to each other to multiply the separate response of 
each activator to the same inducer. Thus, the expression of xylS2 
was coupled to the NahR-dependent P
sal
 promoter in the “regu-
latory module” nahR/P
sal
::xylS2 fusion, which was inserted into 
the bacterial chromosome by means of a mini-Tn5 delivery sys-
tem (Fig. 2A). This allows researchers to clone any protein of 
interest in a plasmid downstream the P
m
 promoter in a so-called 
“expression module” (Fig. 2A). In the absence of salicylate basal 
expression levels are very low, due to the limited concentration 
of inactive XylS2. However, in presence of salicylate NahR acti-
vates transcription from P
sal
, thus producing XylS2 (Fig. 2B). 
Therefore, salicylate activates XylS2, which together with its 
increased intracellular concentration synergistically amplifies 
transcription from the P
m
 promoter present in the expression 
module.28-30 It should be highlighted that the expression module 
can be easily sub-cloned into a mini-Tn5 and inserted in mono-
copy in the bacterial chromosome. Induced expression levels 
using the cascade are so high that overcome the initial puta-
tive disadvantage of changing the expression from multicopy to 
monocopy. In addition, having the expression module inserted 
in the chromosome confers an advantage when stable production 
is desired, or when the use of antibiotics to select the plasmid 
may be an inconvenience.29
magnified by the fact that T7 polymerase is active per se, and this 
constrains the induction ratios.8,9
Expression Systems Based on Pm and Psal
Both xylS/P
m
 and nahR/P
sal
 expression systems have their origin 
in the degradation pathways of toluene and naphthalene from 
Pseudomonas putida. The catabolism of toluene/xylenes in P. 
putida is encoded in a pathway known as TOL pathway. The cat-
abolic genes of pWW0 (also called TOL plasmid) are organized 
into 2 operons, referred to as the upper and lower (or meta) path-
ways. The xyl genes of the P. putida TOL plasmid that specify 
catabolism of toluene and xylenes are organized in 4 transcrip-
tional units: the upper-operon (xylUWCAMBN) for conversion 
of toluene/xylenes into benzoate/alkylbenzoates; the meta-operon 
(xylXYZLTEGFJQKIH) that encodes the enzymes for further 
conversion of these compounds into Krebs cycle intermediates; 
and XylS and XylR proteins which are involved in transcriptional 
control. The xylS/P
m
 expression system has been fully charac-
terized in different genetic backgrounds.10,11 The XylS together 
with AraC define the XylS/AraC family of transcriptional regu-
lators,12 which is present in more than 47 different genera and 
87 species of microorganisms.13 XylS is naturally expressed in its 
inactive form at low levels from its cognitive promoter. In the 
presence of substrates of the meta pathway, such as benzoate or 
m-toluate, XylS activates transcription from the P
m
 promoter.14 
On the other hand, activation of P
m
 promoter by XylS can be 
also triggered by an excess of the regulator (i.e., overexpression 
of XylS) in the absence of inducers.15,16 Recently, a molecular 
model for the mechanism of XylS activation when produced at 
low and high concentrations was proposed, which explains this 
apparent contradiction.17 Many dimeric regulators are in equilib-
rium between their monomeric and dimeric conformation within 
the cell. Dimer formation allows XylS binding to DNA, thereby 
activating transcription from P
m
. Thus, the overproduction of 
XylS in a cascade circuit results in high protein concentrations, 
which shift the equilibrium toward dimerization favoring DNA 
binding.18 However, at low basal XylS levels, which are normally 
found in bacterial cells, the effector (e.g., m-toluate) is required to 
shift the equilibrium toward dimerization.19 The m-toluate favors 
two important conformational changes: (i) alters the direct inter-
actions between the XylS N-terminal and C-terminal domains 
promoting protein dimerization and indirectly XylS DNA bind-
ing, and (ii) opens the regulator DNA-binding domains favoring 
contact with DNA.17 Thus, the presence of an upper pathway 
substrate alone, such as benzyl alcohol, induces XylS overproduc-
tion causing the activation of P
m
, even without XylS effectors. 
Thus, a synergistic effect could be obtained when activation of 
the P
m
 by XylS overproduction is further augmented in the pres-
ence of inducers like m-toluate.20 Induction with m-toluate has 
been used in biotechnological applications such as the production 
of different enzymes (e.g., the CelB phosphoglucomutase from 
Acetobacter xylinum21 or XanA from Xanthomonas campestris, an 
enzyme involved in xantano biosynthesis).10
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RNA polymerase from known or cryptic vector promoters. Thus, 
attenuation could serve to eliminate most of the unwanted tran-
scription produced under non-inducing conditions. On this 
regard, the nasFAD attenuator and the NasR-dependent anti-
termination system from Klebsiella pneumoniae was selected 
to reversibly prevent undesired transcription.36 The presence 
of the nasF attenuator between the regulated P
m
 promoter and 
the gene of interest reduces transcription of the gene by more 
than one order of magnitude under non-inducing conditions 
(Fig. 3A), which indicates the potential of the attenuator to reduce 
the basal expression levels. In order to fully control and revert 
premature termination, NasR should be provided to the circuit. 
However, NasR is not active per se, since requires NO
3
- for being 
active, giving the researcher an additional point of control. Thus, 
transcription anti-termination at the attenuator significantly 
increased under inducing conditions when the expression of the 
NasR gene is coupled to the cascade regulatory circuit by placing 
it downstream of P
sal
 (Fig. 3B). By providing NasR from this pro-
moter, the circuit displayed the highest induction ratio (1,700-
fold), since P
sal
 is weak enough to produce undetectable levels of 
NasR in the absence of salicylate and strong enough to allow full 
anti-termination upon induction.36
Biotechnological applications. Depending on the flexibility 
of the plasmid replication origin, the plasmid number can vary 
between 15–60 copies per cell (such as those derived from pMB1/
ColE1 origin from the pBR322 series, or those derived from the 
Over-Imposed Circuit to Improved  
Salicylate-Dependent Cascade
Most expression systems displaying high induction capacity usu-
ally exhibit high basal levels. This leakiness may be a handicap 
when a potentially toxic protein is expressed, since spontaneous 
mutants are selected. Thus, in the past few years alternatives such 
as efficient repressors or combinations of some of them with other 
strategies have been investigated to create systems with reduced 
basal levels which maintain high-induction ratios.31 One of the 
most helpful strategies in this regard is to include a second regula-
tory control operating at a different regulatory level. An example 
of regulation at a step different from transcription initiation is the 
attenuation of transcription elongation. This regulation has been 
considered a highly sophisticated and useful strategy,32 either 
alone or in combination with repressors or activators, allowing 
a very tight regulation of gene expression.33-35 Attenuation com-
prises a premature transcription stop, due to a RNA conforma-
tion that occurs in the nascent transcript. In order to revert this 
phenomenon, bacteria use a specific RNA-binding regulatory 
protein to control the formation of a terminator structure.
The main characteristic of an attenuation system that makes 
it attractive as a complementary regulatory circuit in expression 
vectors is that it prevents transcription elongation regardless from 
(1) undesired basal transcription from the regulated promoter of 
the expression system or (2) spurious initiation of the bacterial 
Figure 2. Schematic representation of the salicylate-dependent control circuit. (A) The cascade expression system is based on the regulatory module 
(nahR/Psal-XylS2) and the expression module Pm-gene of interest. (B) In the presence of salicylate (inducer), NahR activates transcription from Psal, pro-
ducing XylS2. Salicylate concomitantly activates XylS2, which together with its increased intracellular concentration synergistically amplifies transcrip-
tion from the Pm promoter present in the expression module.
D
ow
nl
oa
de
d 
by
 [R
ed
 de
 B
ibl
iot
ec
as
 de
l C
SI
C]
 at
 01
:30
 09
 Fe
br
ua
ry
 20
16
 
248 Bioengineered Bugs Volume 1 Issue 4
Thus, spurious promoter activity, plasmid read-through or cryp-
tic initiation signals clearly raises basal expression levels of heter-
ologous genes in high-copy number expression vectors,37 thereby 
favoring the appearance of expression-down phenotypes in the 
case of gene expression that decreases the growth rate of the host 
strain.29,37,38 To overcome this problem different approaches have 
been developed to tighten the control of gene expression, such as 
the reduction of gene dosage either by using low-copy number 
plasmids or by chromosome integration.29,39,40 However, these 
modified systems do not sustain a high level of gene expression. 
On this regard the cascade expression system offers a significant 
p15A of the pACYC series) and several hundreds of copies per cell, 
such as the pUC series derived from pMB1. Under lab conditions 
without any selective pressure, these high copy-number plasmids 
are lost at low rates (10-5, 10-6 per generation). However, this 
rate dramatically increases under normal induction conditions, 
or when expressing a toxic product.5 As previously mentioned, 
most prokaryotic expression systems are normally placed on a 
multicopy plasmid to maximize the induced expression levels. 
These simple systems are very useful for small scale production, 
however, a large number of heterologous proteins confer insta-
bility due to a leaky expression under non-induced conditions. 
Figure 3. Schematic representation of the salicylate-dependent control circuit with the over-imposed attenuation regulatory system. (A) The cascade 
expression system is based on the regulatory module (nahR/Psal-XylS2) and the expression module Pm-gene of interest, but it also contains the Psal-nasR 
regulatory module that targets the nasF attenuator (grey box) that is located between the Pm promoter and the gene of interest (grey boxes). (B) In the 
presence of salicylate (inducer), NahR activates transcription from Psal, producing not only XylS2 but also nasR. In the presence of NO3
-, nasR becomes 
activated allowing the elongation from the Pm promoter. Thus, the increased intracellular concentration of XylS2 and the concomitantly activation in 
the presence of salicylate synergistically amplifies transcription from the Pm promoter in the expression module.
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Acetyl-salicylic acid (ASA) is one of the most widely 
used and best characterized analgesic and anti-inflamma-
tory drugs in the market.42 The biological half-life of ASA 
is only 20 min, since it is rapidly converted in the stomach 
and bloodstream into its pharmacological active form, 
the salicylic acid, which has a half-life of approximately 4 
h.42 Thus, given the nature of this drug, its putative use as 
inducer to control heterologous expression in Salmonella 
spp. in vivo was explored. The regulatory module was 
transposed into an attenuated aroA Salmonella, thereby 
generating the SL7207-4S2 strain. The resulting strain 
was further transformed with a plasmid encoding GFP 
under control from the P
m
 promoter. As shown in Figure 
4, the inducer is capable to exert its activity on intracel-
lular bacteria in mammalian cultured cells.43 In addition, 
mice bearing tumors were infected with the S. enterica 
strain SL7207-4S2 carrying the P
m
-gfp encoding plasmid. 
Then, the system was induced by administering salicylate 
and after 4 h flow cytometry analysis showed that 30% 
of the tumor cells were GFP-positive.43 Thus, it could 
be conceived that the nahR/P
sal
::xylS2 expression system 
together with Salmonella spp. could be used in the con-
text of anticancer therapy, by benefiting from Salmonella 
properties to find a niche in hypoxic and necrotic areas 
located inside some solid tumors.44,45 As a proof-of-principle, the 
method was validated by engineering attenuated Salmonella to 
express the fluorocytosine-converting enzyme cytosine deami-
nase that converts the innocuous 5-fluorocytosine (5-FC) into 
5-fluorouracil, a cytotoxic compound routinely used in cancer 
chemotherapy. After infecting mice bearing established tumors 
with the engineered Salmonella, 5-FC was administered. Later, 
aspirin administration was able to turn on the expression of the 
converting enzyme in bacteria residing in tumor cells, thereby 
activating the pro-drug and achieving a significant reduction in 
tumor growth.43
Concluding Remarks
Simple prokaryotic expression systems are usually enough for 
small scale production of proteins at the laboratory, but when 
scaling up, system stability and costs became a major concern. 
Most expression systems are based on a single promoter. The use 
of plasmid-based expression systems resulted in instability or 
appearance of expression-down mutants that rapidly dominate 
the culture. Moreover, the potential toxicity and high cost of the 
inducer (e.g., IPTG) might restrict the industrial application of 
many of these expression systems.30,46,47 Thus, the development of 
cost-efficient approaches to control gene overexpression is a criti-
cal issue in biotechnology.48
The salicylate inducible cascade expression system allows 
tightly regulated expression in response to an inexpensive inducer 
such as salicylate. In addition, the system based on two physi-
cally separated regulatory and expression modules provides a 
great flexibility, allowing the cloning of the expression module in 
a plasmid (either high or low copy number plasmids) or into the 
chromosome. Although stability is not always a major concern 
advantage. The synergic effect that involves the nahR/P
sal
::xylS2 
system allows diminishing the basal level (70–90%), maintain-
ing just half of the maximum induction ratios obtained from 
a multicopy plasmid, but resulting in a relative increase on the 
induction ratio (from 60 to 250-fold).
Even in the absence of product toxicity and using antibiotic 
selection to prevent plasmid loss, the overproduction phenotype 
from a plasmid configuration is unstable, most probably due to 
the impossibility of the bacterial machinery to replicate the plas-
mid while keeping high transcription levels.29,30 This leads to the 
appearance of down-expression mutants, unless the expression 
system is stabilized by insertion into the chromosome. Therefore, 
in terms of biotechnological production the cascade system in 
the chromosome configuration combines high levels of expres-
sion with great stability of the overproduction phenotype. This in 
turn results in protein yields that are at least 1 order of magnitude 
higher than those of expression systems from plasmids, when the 
time of fermentation is greater than 24 h.30
Use of nahR/Psal::xylS2 Expression System to Study 
Bacteria-Host Interaction in vivo
Most systems used in biotechnology are not suitable for stud-
ies involving bacterial behavior inside mammalian cells. In fact, 
several in vivo prokaryotic inducible expression systems used that 
respond to external stimuli, such as the tetracycline responsive 
bacterial tetracycline repressor, are limited for studying host-
pathogen interactions by toxicity, side effects of their inducers 
and leakiness of their expression. Experimental approaches for 
functional investigation of genes using finely controlled expres-
sion systems (‘on-off ’) in vivo are highly desirable, but are not 
well developed for microbial studies.41
Figure 4. Fluorescence microscopy image of F1.A11 tumor cells infected with 
SL7207-4S2 containing the gfp-encoding vector after induction of protein  
expression (GFP) with 2 mM salicylate.
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gross phenotypic defect. However, this “all-or-none” approach 
has many limitations, particularly for the analysis of a complex 
or subtle phenotype. This is the case when the contribution of 
the gene product should be analyzed in temporal and spatial 
context. Thus, the exploitation of an inducer of well-known 
pharmacological properties, such as aspirin, to turn on expres-
sion of a bacterial gene inside an infected host provides a new 
tool not only for developing bacterial-based therapies, but also 
for studying host-pathogen interactions and the specific role 
played by putative virulence factors during the course of infec-
tion. By the use of this type of circuits it would be possible 
to switch-on the expression of selected genes at will, thereby 
assessing their role during the course of the infection process 
and/or bacterial transit through specific anatomical niches. 
Thus, the salicylate regulatory control circuit may constitute a 
cornerstone for biotechnological applications, as well as func-
tional studies of bacteria-host interactions, due to its flexibility 
and broad-range use.
in research or small scale production, it is on industrial produc-
tion or for in vivo applications. Thus, the expression module 
could be integrated into chromosome, when stable production is 
desired or the use of antibiotic should be avoided. The induced 
expression levels using the cascade are so high that the expression 
module from plasmid (multicopy) to chromosome (monocopy) 
configuration could be changed without the putative disadvan-
tage of reduced gene dosage. Therefore, this cascade regulatory 
circuit not only improves the control of heterologous gene expres-
sion, but also shows a multilevel regulation operating at different 
steps of the expression process. This broadens the possibilities 
with respect to simple control systems in terms of increasing the 
induction ratios and fine-tuning expression levels.
In addition to its biotechnological use, cascade systems such 
as the one regulated by salicylate can be exploited to overcome 
the problem of gene functional studies, both in vitro and in 
vivo. Currently, the most common approach to study gene 
function is a gene inactivation approach and then looking for a 
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